Risk Factors for Valvulopathy Among Childhood Cancer Survivors

20253 citationsJournal Articlegreen Open Access

Authors

Rivalin Aho Glele · Inserm

Elizabeth A. M. Feijen · Princess Máxima Center

Brice Fresneau · Inserm

Raoul C. Reulen · NIHR Birmingham Biomedical Research Centre

Rodrigue S. Allodji · Institut Gustave Roussy

Giao Vu‐Bezin · Centre de recherche en Epidémiologie et Santé des Populations

Boris Schwartz

Abstract

In this case-control study, heart RT, anthracyclines, and platinum agents were associated with increased VHD risk in childhood cancer survivors. Risks from both RT and anthracyclines were amplified with age and follow-up, underscoring the need for long-term cardiac surveillance.

Topics & Keywords

Chemotherapy-induced cardiotoxicity and mitigation Childhood Cancer Survivors' Quality of Life Congenital Diaphragmatic Hernia Studies

Publication Details

Published in: JAMA Oncology

Volume 11, Issue 12, pp. 1449-1449

DOI: 10.1001/jamaoncol.2025.3863

Field-Weighted Citation Impact: 4.61

Command Palette

Risk Factors for Valvulopathy Among Childhood Cancer Survivors

Authors

Abstract

Topics & Keywords

Publication Details